IRON MOUNTAIN INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that IRON MOUNTAIN INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $4.49B | Feb 24, 2022 |
| FY2021 | Dec 31, 2020 | $4.15B | Feb 24, 2022 |
| FY2019 | Dec 31, 2019 | $1.08B | Feb 13, 2020 |
| FY2019 | Sep 30, 2019 | $1.06B | Feb 13, 2020 |
| FY2019 | Jun 30, 2019 | $1.07B | Feb 13, 2020 |
| FY2019 | Mar 31, 2019 | $1.05B | Feb 13, 2020 |
| FY2020 | Dec 31, 2018 | $4.23B | Feb 24, 2021 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.90B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $6.15B | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $5.48B | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $5.10B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $4.49B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $4.15B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $1.58B | Feb 24, 2022 |
| FY2019 | Dec 31, 2018 | $1.06B | Feb 13, 2020 |
| FY2019 | Sep 30, 2018 | $1.06B | Feb 13, 2020 |
| FY2019 | Jun 30, 2018 | $1.06B | Feb 13, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2010 | Dec 31, 2010 | ($53.90M) | Mar 1, 2011 |
| FY2010 | Dec 31, 2009 | $220.88M | Mar 1, 2011 |
| FY2010 | Dec 31, 2008 | $82.04M | Mar 1, 2011 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.16B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $1.01B | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $921.78M | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $1.05B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $854.17M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $934.79M | Feb 23, 2023 |
| FY2019 | Dec 31, 2019 | $206.07M | Feb 13, 2020 |
| FY2019 | Sep 30, 2019 | $223.47M | Feb 13, 2020 |
| FY2019 | Jun 30, 2019 | $193.12M | Feb 13, 2020 |
| FY2019 | Mar 31, 2019 | $158.68M | Feb 13, 2020 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $21.13B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $18.72B | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $17.47B | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $16.14B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $14.45B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $14.15B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $13.82B | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $11.86B | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | $10.98B | Feb 13, 2020 |
| FY2018 | Dec 31, 2016 | $9.49B | Feb 14, 2019 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($981.01M) | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | ($503.12M) | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $211.65M | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $636.67M | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $855.95M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $1.14B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $1.46B | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $1.86B | Feb 13, 2020 |
| FY2018 | Dec 31, 2017 | $2.30B | Feb 14, 2019 |
| FY2017 | Dec 31, 2016 | $1.94B | Feb 16, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | 1 | Feb 23, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Feb 13, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Feb 13, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Feb 13, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Feb 13, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | 1 | Feb 23, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Feb 13, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Feb 13, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Feb 13, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Feb 13, 2020 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $158.54M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $155.72M | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $222.79M | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $141.80M | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $255.83M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $205.06M | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $193.56M | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $165.49M | Feb 13, 2020 |
| FY2018 | Dec 31, 2017 | $925.70M | Feb 14, 2019 |
| FY2018 | Dec 31, 2016 | $236.48M | Feb 14, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $16.43B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $13.72B | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $11.93B | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $10.57B | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $9.27B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $8.70B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $8.66B | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $8.14B | Feb 13, 2020 |
| FY2018 | Dec 31, 2017 | $7.04B | Feb 14, 2019 |
| FY2017 | Dec 31, 2016 | $6.25B | Feb 16, 2018 |